4//SEC Filing
Rasdal Andrew P 4
Accession 0001214659-18-003245
CIK 0001427570other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 7:23 AM ET
Size
4.8 KB
Accession
0001214659-18-003245
Insider Transaction Report
Form 4
Rasdal Andrew P
DirectorPresident & CEO
Transactions
- Award
Common Stock
2018-04-30$3.27/sh+2,987$9,767→ 457,058 total
Footnotes (1)
- [F1]These shares were acquired under the Obalon Therapeutics, Inc. 2016 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
OBALON THERAPEUTICS INC
CIK 0001427570
Entity typeother
Related Parties
1- filerCIK 0001323238
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 7:23 AM ET
- Size
- 4.8 KB